|Articles|October 1, 2010
- BioPharm International-10-01-2010
- Volume 23
- Issue 10
BioPharm International, October 2010 Issue (PDF)
Biopharmaceutical Approvals in the US and EU: A Review
Advertisement
Articles in this issue
about 15 years ago
Uncertain Outlook for Biopharma Venture Capitalabout 15 years ago
Biopharmacetiucal Approval Trends in 2009about 15 years ago
A Quality Culture Can Be the Industry's Core Strengthabout 15 years ago
Biotech Companies Gain Support for Vaccine, Countermeasure Productionabout 15 years ago
Taking on the Challengesabout 15 years ago
Biotech Cools Off as Capital Markets Weakenabout 15 years ago
The Role of Noncritical Process Parameters in Quality by DesignNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
